---
title: "Gap Between AHA/ASA Stroke Guidelines and Care in Kiambu County, Kenya"
id: "medrxiv-11-stroke-care-in-rural-kenya-the-gap-between-clinical-practice-and-stroke-care"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-11-stroke-care-in-rural-kenya-the-gap-between-clinical-practice-and-stroke-care"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.09.26365112v1?rss=1"
published_at: "2026-10-12T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Gap Between AHA/ASA Stroke Guidelines and Care in Kiambu County, Kenya
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-11-stroke-care-in-rural-kenya-the-gap-between-clinical-practice-and-stroke-care
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.09.26365112v1?rss=1)
- **Published At:** 2026-10-12T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The investigators reviewed stroke records at a peri-urban referral hospital in Kiambu County from January 1, 2020, to December 31, 2023, comparing local practice with the **AHA/ASA Guidelines** for early ischemic stroke care. - The cohort travelled a median distance of 47.8 kilometres to reach care, and the median onset-to-presentation time was 24 hours, indicating substantial prehospital delays. - The facility lacked a dedicated **stroke unit**, which the study team observed as a structural barrier to organized stroke care delivery. - Investigators evaluated eight clinical practices against guideline standards; the report notes minimal adherence overall but does not enumerate all eight practices in detail. - Patients who presented within the therapeutic windows for intravenous **alteplase** and **thrombectomy** did not receive these reperfusion treatments; the source did not report specific counts or reasons for omission. - Secondary prevention adherence was mixed: among 86 eligible ischemic stroke patients, 67 (77.9%) were discharged on **antiplatelet** therapy (aspirin), and 84 of 123 patients (68.3%) were discharged on **statin** therapy. - The study authors concluded that evidence-based recommendations were minimally adhered to at this peri-urban referral facility and framed the findings as context-specific evidence to guide quality-improvement and guideline-implementation efforts in resource-constrained settings. - The source did not report detailed dosing, exact timing of presentations relative to therapeutic windows, nor granular reasons for failure to deliver reperfusion therapies; those methodological gaps limit causal interpretation.
## Clinical Analysis & Structured Key Points
Background In Kenya, stroke is one of the top five causes of mortality, with a high rate of inpatient mortality. The American Heart Association (AHA) and American Stroke Association (ASA) translated scientific evidence into evidence-based clinical practice guidelines aimed at reducing inpatient mortality and improving the quality of care for stroke patients. Despite the proven benefits of the ASA stroke guidelines in improving stroke care, translation of the guidelines in various settings remains a key challenge. This study aimed to quantify the gap between evidence-based recommendations and current stroke care practices in a peri-urban referral facility in Kiambu, Kenya. The study was conducted at xxxxxxxxxx Hospital, a peri-urban referral facility in Kiambu County, Kenya. Methods: We reviewed records of stroke patients attending xxxxxxxxxxx from January 1, 2020, to December 31, 2023. The study evaluated acute stroke management practices and secondary prevention against the 2019 American Heart Association/American Stroke Association (AHA/ASA) Guidelines for the Early Management of Acute Ischemic Stroke. Results: The median distance travelled by stroke patients to the facility was 47.8 kilometres; further, the median onset-to-presentation time was 24 hours. The study evaluated eight clinical practices against the ASA guidelines. The facility lacked a dedicated stroke unit. Remarkably, patients arriving within the therapeutic window for intravenous alteplase and thrombectomy did not receive these treatments. Secondary prevention measures, including discharge on an antiplatelet regimen, were moderately adhered to; among the 86 eligible ischemic stroke patients, 67 (77.9%) were correctly discharged on aspirin. Similarly, 84/123 (68.3%) of the patients were discharged on statin therapy. Conclusion: Evidence-based stroke care recommendations were minimally adhered to at this peri-urban referral facility in Kiambu, Kenya. Contribution: This study quantifies the gap between evidence-based stroke care recommendations and current clinical practice in a peri-urban referral facility in Kenya, providing context-specific evidence to inform quality improvement initiatives and guideline implementation efforts in similar resource-constrained settings.
## Related Clinical Research

- [Young-onset stroke in the UAE: risk factors, subtypes, and outcomes from a single-centre study](https://medichelpline.com/clinical-feed/plos-one-19-young-onset-stroke-in-the-uae-a-single-centre-retrospective-analysis-of-risk.md)
- [Early-event pathways to 6-month death or dependency after ischemic stroke — analysis of the Intern](https://medichelpline.com/clinical-feed/pubmed-42263448.md) (DOI: 10.1016/j.jns.2026.126044)
- [Bupropion Hydrochloride for Improving Recovery in Acute Ischaemic Stroke: BASE Trial Protocol](https://medichelpline.com/clinical-feed/bmj-open-4-protocol-for-base-a-multicentre-double-blind-randomised-controlled-trial-of.md)
- [Base excess and alactic base excess predict KDIGO stage 2–3 AKI in acute ischemic stroke ICU patie](https://medichelpline.com/clinical-feed/pubmed-42867193.md) (DOI: 10.5414/CN112097)
- [Isothiocyanate mixture inhibits platelet signaling and mitochondrial metabolism to reduce thrombos](https://medichelpline.com/clinical-feed/frontiers-in-immunology-6-a-defined-isothiocyanate-mixture-suppresses-platelet-signaling-and-metabolism.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.